Clinical Trials Logo

Mechanical Ventilation clinical trials

View clinical trials related to Mechanical Ventilation.

Filter by:

NCT ID: NCT04497454 Recruiting - Clinical trials for Mechanical Ventilation

Mechanical Ventilation Strategy for Coronavirus Disease 2019 (COVID-19)

COVEN
Start date: May 8, 2020
Phase: N/A
Study type: Interventional

This is a prospective, randomized, single-center, open-label controlled trial, designed to compare the efficacy of two ventilation strategies (Low Tidal Volume and positive end-expiratory pressure (PEEP) based on the Acute Respiratory Distress Syndrome (ARDS) Network low PEEP-fraction of inspired oxygen inspired oxygen fraction (FIO2) Table versus Low Driving Pressure and PEEP guided by Electrical Impedance Tomography (EIT) in reducing daily lung injury score in patients with acute respiratory distress syndrome caused by COVID-19. The two strategies incorporate different prioritizations of clinical variables. The PEEP-FIO2 table strategy aims to reduce lung overdistension, even if it requires tolerating worse gas exchange. EIT-guided strategy prioritizes mechanical stress protection, avoiding alveolar overdistension and collapse.

NCT ID: NCT04489615 Recruiting - Clinical trials for Mechanical Ventilation

Identification of Risk Factors for Alteration of the Cellular-arterial Gradient of CO2

DELTA-CAPNO
Start date: June 3, 2020
Phase:
Study type: Observational [Patient Registry]

Monocentric, prospective, observational and descriptive study on the evaluation of risk factors for alteration of the alveoarterial gradient of CO2 in pre-hospital patients, intubated and then ventilated in an invasive manner; and their impact on intra-arterial fatehospital.

NCT ID: NCT04482556 Recruiting - Clinical trials for Mechanical Ventilation

Comparison of the Q-NRG+ Indirect Calorimetry Device Versus the V(Max) Encore Device in Mechanically Ventilated Children

Start date: January 1, 2020
Phase: N/A
Study type: Interventional

The overarching aim of this proposal is to examine the feasibility of the Q-NRG+ indirect calorimetry device and its agreement with (Vmax) Encore indirect calorimetry device in mechanically ventilated children. The overall hypothesis of this study is that the Q-NRG+ will provide minute-to-minute oxygen consumption (VO2) and carbon dioxide production (CO2) measurements that are in agreement with those obtained by the standard indirect calorimetry device currently used at our institution (Vmax Encore).

NCT ID: NCT04481581 Recruiting - Clinical trials for Mechanical Ventilation

Titration of Oxygen Levels During Mechanical Ventilation With Electronic Alerts

TOOLs
Start date: January 5, 2021
Phase: N/A
Study type: Interventional

Fractional oxygen during mechanical ventilation, is a life sustaining therapy in the intensive care unit , used for about a million patients annually. Oxygen therapy needs to be tightly balanced as both hypoxia and hyperoxia are harmful. Establishing precision in oxygenation has significant implications for improving patient outcomes, resource utilization and reducing iatrogenic harm to a vulnerable population. The investigators propose an approach using a oxygen titration protocol consisting of electronic health records based alerts to guide oxygen adjustment.

NCT ID: NCT04459884 Recruiting - Clinical trials for Mechanical Ventilation

Multicenter Observational Study on Practice of Ventilation in Brain Injured Patients

Start date: August 23, 2021
Phase:
Study type: Observational [Patient Registry]

Rationale Several experimental and clinical studies have shown how brain injury can cause secondary lung injury. Lung injury could be due either to mechanical ventilation- often necessary in brain injured patients- or to inflammatory response that follows primary acute brain injury. The concept of 'Protective lung ventilation' has shown to reduce morbidity and mortality of intensive care unit (ICU) patients with acute respiratory distress syndrome (ARDS) but seems also to have a beneficial effect on patients with healthy lungs and in the perioperative settings. However, these recommendations often come into conflict with the management of patients affected by acute brain injury, in which permissive hypercapnia and increased intrathoracic pressure as consequence of protective ventilation strategies can be dangerous. Study design This is an international multi-center prospective observational study. Study population This study will include all consecutive brain injured patients (traumatic brain injury (TBI) or cerebrovascular) intubated and ventilated in ICU and observed for a 7-day period. Nature and extent of the burden and risks associated with participation, benefit and group relatedness Seen the observational design of the study, there is no patient burden. Collection of data from ICU and hospital charts and/or (electronic) medical records systems is of no risk to patients.

NCT ID: NCT04455477 Recruiting - Clinical trials for Congestive Heart Failure

Nesiritide for Ventilated Congestive Heart Failure

HENCHF
Start date: May 14, 2020
Phase:
Study type: Observational

The congestive heart failure is a common disease among patients who receive cardiac surgery and may lead to prolonged ventilation support. Nesiritide was a potential therapy for congestive heart failure. This study aimed to compare the Nesiritide induced hemodynamical status changes among congestive heart failure patients with invasive ventilation support.

NCT ID: NCT04381286 Recruiting - COVID-19 Clinical Trials

Transpulmonary Driving Pressure in ARDS COVID19 Patients

TRANSPULMONARY
Start date: April 1, 2019
Phase:
Study type: Observational

A majority (65-85%) of critically ill patients admitted in intensive care units with a confirmed diagnostic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) developed an acute respiratory distress syndrome (ARDS) according to BERLIN criteria. Gattinoni et al. recently described that the ARDS related to SARS-CoV-2 was not a "Typical" ARDS. Patients affected by this infection present indeed a major hypoxemia, which was surprisingly associated in early phase with a high compliance of respiratory system, more than 50 ml/cm H2O in most cases. The cornerstone of current treatment in case of ARDS is the use of "lung protective" ventilation, including limited tidal volumes (VT), low end-inspiratory plateau pressures while maintaining sufficiently-high positive end-expiratory pressures (PEEP). However, high levels of PEEP in patients may have detrimental effects on hemodynamic status and fluid retention, particularly when the respiratory system compliance is normal. High PEEP may also lead to overdistension and an increase of alveolar dead space. The airway pressures commonly monitored does not reliably reflect the impact of pressures on the lung parenchyma. Elastance of chest wall may indeed largely influence values of airways pressions. In contrast, transpulmonary pressure obtained using esophageal pressure (Pes) directly reflect lung overdistension risk and lung properties. In order to better understand this new kind of ARDS characterized by modest recruitable profile and to better personalize mechanical ventilation setting and therapy it is obvious to precise transpulmonary pressure.

NCT ID: NCT04193540 Recruiting - Clinical trials for Mechanical Ventilation

Evaluation of Decision Capacity of ICU Patients Under Sedatives. A Prospective Observational Multicenter Study.

DexCap
Start date: July 15, 2018
Phase:
Study type: Observational

This prospective observational multicenter study is intended to investigate the impact of sedatives on the decision capacity of intensive care units patients.

NCT ID: NCT04110613 Recruiting - Surgery Clinical Trials

RCT: Early Feeding After PEG Placement

PEG
Start date: September 19, 2019
Phase: N/A
Study type: Interventional

Randomized controlled trial to establish evidence on which to base timing of enteral feeding after bedside PEG placement in ventilated Trauma and Surgical ICU patients.

NCT ID: NCT04080440 Recruiting - Clinical trials for Mechanical Ventilation

Brain-injured Patients Extubation Readiness Study

Biper
Start date: February 9, 2020
Phase: N/A
Study type: Interventional

The BIPER study is a stepped wedge cluster randomised clinical trial aiming to decrease extubation failure in critically-ill brain-injured patients with residual impaired consciousness using a simple clinical score.